We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · September 10, 2019

Hyperkalemia in Women With Acne Exposed to Oral Spironolactone

International Journal of Women's Dermatology


Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of Women's Dermatology
Hyperkalemia in Women With Acne Exposed to Oral Spironolactone: A Retrospective Study From the RADAR (Research on Adverse Drug Events and Reports) Program
Int J Womens Dermatol 2019 Jul 01;5(3)155-157, RM Thiede, S Rastogi, B Nardone, LM Sadowsky, SM Rangel, DP West, BJ Schlosser

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading